Precision Oncology 2.0: Guiding Magic Bullets With Expression-Based Liquid Biopsy
G
Gunsagar S. Gulati
T
Toni K. Choueiri
(Department of Medical Oncology Dana‐Farber Cancer Institute Boston Massachusetts USA)
M
Matthew L. Freedman
S
Sylvan C. Baca
(Dana-Farber Cancer Institute, Boston, MA)
Article Details
Journal
Journal of Clinical Oncology
Volume / Issue
Vol. 44, Issue 11
Published
April 10, 2026
Pages
953-958
ISSN
0732-183X
Publisher
Lippincott Williams & Wilkins
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
ISSN: 0732-183X Health Sciences
Authors (4)
G
Gunsagar S. Gulati
T
Toni K. Choueiri
Department of Medical Oncology Dana‐Farber Cancer Institute Boston Massachusetts USA
M
Matthew L. Freedman
S
Sylvan C. Baca
Dana-Farber Cancer Institute, Boston, MA
Related Articles from this Journal
Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer
Ismaela Anna Vascotto, Filippo Antonica et al.
Aug 2026
10.1200/jco-26-00658
Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial
Samer A. Srour, Jad Chahoud et al.
Aug 2026
10.1200/jco-26-00388
Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection
Risako Komata, Kenju Ando et al.
Aug 2026
10.1200/jco-26-00140
Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)
Ghayas C. Issa, Branko Cuglievan et al.
Aug 2026
10.1200/jco-26-01743
Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer
Irbaz Bin Riaz, R. Bryan Rumble et al.
Aug 2026
10.1200/jco-26-01001